insights_auto
Why is PGEN down 2.58%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$4.54
arrow_downward
-2.58%(-0.12) 1D
$4.52
arrow_downward
-0.44% (-0.020)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$4.66
High
$4.71
Low
$4.51
Mkt. cap
1.63B
Avg. vol.
6.85M
Volume
3.78M
P/E ratio
101.52
52-wk high
$8.98
52-wk low
$3.04
EPS
$0.04
Beta
1.01
Shares outstanding
358.55M
No. of employees
160
Open
$4.66
High
$4.71
Low
$4.51
Mkt. cap
1.63B
Avg. vol.
6.85M
Volume
3.78M
P/E ratio
101.52
52-wk high
$8.98
52-wk low
$3.04
EPS
$0.04
Beta
1.01
Shares outstanding
358.55M
No. of employees
160
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
CNBC
·
1 day ago
Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump
Yahoo Finance
·
1 day ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Foreign Policy Journal
·
31 minutes ago
AST SpaceMobile (NASDAQ: ASTS) Carries A $10.4 Billion Valuation While Its Biggest New Contract Is Worth Just 1% Of That
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteprecigen.com